Waylis Therapeutics is based in the state of New Jersey in the United States. The organization produces a range of items including Valium (Diazepam), Eulexin (Flutamide), Humatin (Paromomycin), Leukeran (Chlorambucil), Myleran (Busulfan), and Tabloid (Thioguanine).
Waylis Therapeutics
Headquarters
United States of America